Cidara Therapeutics, Inc. (NASDAQ:CDTX) Sees Large Drop in Short Interest

Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Free Report) was the recipient of a significant decline in short interest in the month of December. As of December 15th, there was short interest totalling 36,100 shares, a decline of 31.6% from the November 30th total of 52,800 shares. Based on an average daily volume of 45,100 shares, […]

Leave a Reply

Your email address will not be published.

Previous post LifeVantage (NASDAQ:LFVN) versus Assembly Biosciences (NASDAQ:ASMB) Head-To-Head Comparison
Next post Times Square ball takes final test for New Year’s Eve